CM Management »

ACADIA Pharmaceuticals shares owned by CM Management

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by CM Management from 13F filings

Historical chart of CM Management investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by CM Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by CM Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $740k 40k 18.49
2023-12-31 $939k 30k 31.31

More positions owned by CM Management

Ali (ALCO)
Taseko Cad (TGB)
Amicus Therapeutics (FOLD)
Royalty Pharma (RPRX)
Newmark Group Com - Class A (NMRK)
Arko Corp (ARKO)
Radiant Logistics (RLGT)
Iovance Biotherapeutics (IOVA)
American Superconductor (AMSC)
Preformed Line Products Company (PLPC)
Kyndryl Holdings Ord Wi (KD)
Walgreen Boots Alliance (WBA)
inTEST Corporation (INTT)
Rigel Pharmaceuticals (RIGL)
Pagerduty (PD)

View all positions for CM Management

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
BlackRock
EcoR1 Capital
T. Rowe Price Associates
FMR
Geode Capital Management
D. E. Shaw & Co
Palo Alto Investors
Fred Alger Management
Millennium Management
Emerald Advisers
First Trust Advisors
Jupiter Asset Management
Morgan Stanley

View all funds holding ACADIA Pharmaceuticals